VanEck Associates’s LivaNova LIVN Stock Holding History

VanEck Associates’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,018	Closed	-$262K	–	1438
2023 Q1	$262K	Sell	6,018 -1,729	-22%	-$87.5K	﹤0.01%	1126
2022 Q4	$430K	Buy	+7,747	New	+$396K	﹤0.01%	950

Other funds holding LIVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $3.12B AUM 53.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates's LIVN Position: Q2 2023 in Review

VanEck Associates sold out of LivaNova (LIVN) in Q2 2023, closing a stake of 6,018 shares — an estimated $262K sold.

VanEck Associates first reported a position in LIVN in Q4 2022 and held it in 2 quarters. The position peaked at $430K in Q4 2022. 200 funds tracked by Wall St. Rank hold LIVN as of Q2 2023.

VanEck Associates reported no remaining LivaNova position as of Q2 2023 after selling out during the quarter.
VanEck Associates sold 6,018 LivaNova shares in Q2 2023, an estimated $262K.
VanEck Associates first reported a position in LivaNova in Q4 2022 and held it in 2 quarters.
VanEck Associates's LivaNova position peaked at $430K in Q4 2022.
200 funds tracked by Wall St. Rank held LivaNova as of Q2 2023.

Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.